Eledon Pharma Stock (NASDAQ: ELDN) stock price, news, charts, stock research, profile.
Open | $2.050 |
Close | $2.060 |
Volume / Avg. | 81.544K / 87.633K |
Day Range | 2.000 - 2.080 |
52 Wk Range | 1.070 - 2.950 |
Market Cap | $49.874M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 0.48% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eledon Pharma (NASDAQ: ELDN) through any online brokerage.
Other companies in Eledon Pharma’s space includes: NKGen Biotech (NASDAQ:NKGN), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).
The latest price target for Eledon Pharma (NASDAQ: ELDN) was reported by HC Wainwright & Co. on Friday, March 22, 2024. The analyst firm set a price target for 13.00 expecting ELDN to rise to within 12 months (a possible 546.77% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Eledon Pharma (NASDAQ: ELDN) is $2.01 last updated April 26, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Eledon Pharma.
Eledon Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Eledon Pharma.
Eledon Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.